Skip to main content
. 2019 May 9;8(4):261–268. doi: 10.4103/eus.eus_14_19

Appendix A.

Different needles performance on pancreatic lesions

Performance 20 PC (n=236) 19 PC (n=11) 22 PC (n=111) 25 PC (n=70)
Age, years (mean±SD) 68.3±11.8 64.9±8.4 64.7±12.6 70.2±9.8
Number of passes (mean±SD) 2.8±1.0 1.6±0.8 2.8±1.3 2.9±0.8
Lesion site, n (%)
 Pancreatic head and uncinated process 150 (63.6) 4 (36.3) 73 (65.7) 58 (82.8)
 Pancreatic body 64 (27.1) 7 (63.7) 34 (30.6) 11 (15.8)
 Pancreatic tail 22 (9.3) 0 4 (3.7) 1 (1.4)
Diagnostic adequacy, n (%) 218 (92.4) 10 (90.1) 98 (88.3) 61 (87.1)
Diagnostic performance for malignant lesions, % (95% CI)
 Overall accuracy 91.5 (87.2-94.7) 90.9 (58.7-99.8) 88.3 (80.8-93.6) 90 (80.5-95.9)
 Sensitivity 90.8 (86.1-94.3) 90.9 (58.7-99.8) 87.5 (79.6-93.2) 88.5 (77.8-95.3)
 Specificity 100 (82.4-100) - 100 (59-100) 100 (66.4-100)
 Positive predictive value 100 (98.1-100) 100 (69.2-100) 100 (96-100) 100 (93.4-100)
Negative predictive value 48.7 (32.4-65.2) 0 (0-97.5) 35 (15.4-59.2) 56.2 (29.9-80.2)
Number needed to diagnose (NND) 1.1 (1.1-1.5) - 1.1 (1.1-2.6) 1.1 (1.1-2.3)
Number needed to misdiagnose (NNM) 11.8 (7.8-18.9) 11 (2.4-500) 8.5 (5.2-15.6) 10 (5.1-24.4)